# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-104626
Filing Date
2025-08-07
Accepted
2025-08-07 09:07:10
Documents
73
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | nuvb-20250630.htm iXBRL | 10-Q | 3342233
2 | EX-10.1 | nuvb-ex10_1.htm | EX-10.1 | 28081
3 | EX-31.1 | nuvb-ex31_1.htm | EX-31.1 | 17875
4 | EX-31.2 | nuvb-ex31_2.htm | EX-31.2 | 17965
5 | EX-32.1 | nuvb-ex32_1.htm | EX-32.1 | 9524
6 | EX-32.2 | nuvb-ex32_2.htm | EX-32.2 | 8286
| Complete submission text file | 0000950170-25-104626.txt |  | 12136933

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | nuvb-20250630.xsd | EX-101.SCH | 1433510
76 | EXTRACTED XBRL INSTANCE DOCUMENT | nuvb-20250630_htm.xml | XML | 2341010

Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39351 | Film No.: 251191979
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)